Adicet Bio, Inc. Finance Lease, Liability, Payments, Due in Rolling Year Five
Adicet Bio, Inc. (ACET) had Finance Lease, Liability, Payments, Due in Rolling Year Five of $0 as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Leases › Finance Lease, Liability, to be Paid, Rolling Maturity
us-gaap:FinanceLeaseLiabilityPaymentsDueInRollingYearFive · last filed 2026-08-05
- 2026-06-30: Finance Lease, Liability, Payments, Due in Rolling Year Five $0.00.
- 2026-03-31: Finance Lease, Liability, Payments, Due in Rolling Year Five $0.00.
- 2025-12-31: Finance Lease, Liability, Payments, Due in Rolling Year Five $250.00K.
- 2025-09-30: Finance Lease, Liability, Payments, Due in Rolling Year Five $250.00K.
| Period end | Finance Lease, Liability, Payments, Due in Rolling Year Five |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-05 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 |
| 2025-12-31 | $250.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $250.00K 10-Q · filed 2025-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |